OMCL logo

Omnicell (OMCL)

Profile

Full Name

Omnicell, Inc.

Ticker Symbol

OMCL

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

August 9, 2001

Indexes

Not included

Website

http://www.omnicell.com

Employees

3670

Key Details

Price

$30.28(-2.16%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.11B(-3.04% YoY)

Annual EPS

$0.27(+160.00% YoY)

PE ratio

112.15

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$30.28
OMCL price is $30.28

30-Day Relative Volume

1.03
OMCL 30-day relative volume is 1.03

Price Performance

Price Most recent change

-2.16%
OMCL price was down -2.16% on Apr 17, 2025

Price YTD change

-31.99%
OMCL price is down -31.99% since January 1st

Price 1-year change

+15.26%
OMCL price is up +15.26% year-on-year

Price 3-year change

-74.75%
OMCL price is down -74.75% over the past 3 years

Price Range

Price All-time high

$187.29
OMCL price is currently -83.83% below its historical high of $187.29

Price 3-year low

$25.12
OMCL price is currently +20.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.42B
OMCL market capitalization is $1.42 billion

Market cap 3-year change

-73.27%
OMCL market capitalization is down -73.27% over the past 3 years

Market cap All-time high

$8.07B
OMCL market capitalization is currently -82.45% below its historical high of $8.07 billion

Market cap sector rank

79.59%
OMCL market capitalization is higher than 79.59% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.82%
OMCL shares outstanding is up +1.82% year-on-year

Shares Outstanding 3-Year Change

+5.85%
OMCL shares outstanding is up +5.85% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.57
OMCL beta is 0.57

200-day SMA

$40.29
OMCL price is currently -24.84% below its 200-day simple moving average

50-day SMA

$35.88
OMCL price is currently -15.60% below its 50-day simple moving average

RSI

33.53
OMCL 14-day relative strength index is 33.53

Volume

1.03
OMCL 30-day relative volume is 1.03

ATR

$1.50
OMCL average true range is $1.50

10-day Historical Volatility

55.50%
OMCL 10-day historical volatility is 55.50%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.11B
OMCL annual revenue is $1.11 billion

Revenue Analysts estimate

$1.13B
OMCL annual revenue is currently -1.71% lower than the consensus analysts' forecast

Revenue 1-year change

-3.04%
OMCL annual revenue is down -3.04% year-on-year

Revenue Sector rank

80.83%
OMCL annual revenue is higher than 80.83% of companies in Healthcare sector

EPS

EPS

$0.27
OMCL annual earnings per share is $0.27

EPS Analysts estimate

$1.77
OMCL annual earnings per share is currently -84.72% lower than the consensus analysts' forecast

EPS 1-year change

+160%
OMCL annual earnings per share is up +160% year-on-year

EPS Sector rank

85.34%
OMCL annual earnings per share is higher than 85.34% of companies in Healthcare sector

Profit

Gross profit

$471.00M
OMCL annual gross profit is $471.00 million

Gross margin

42.35%
OMCL annual gross profit margin is 42.35%

Operating profit

$337.00K
OMCL annual operating income is $337.00 thousand

Operating margin

0.03%
OMCL annual operating profit margin is 0.03%

Net income

$12.53M
OMCL annual net profit is $12.53 million

Net margin

1.13%
OMCL annual net profit margin is 1.13%

Expenses

Total expenses

$1.11B
OMCL annual total expenses is $1.11 billion

Operating expenses

$470.67M
OMCL annual total operating expenses is $470.67 million

Cost of goods sold

$641.24M
OMCL annual cost of goods sold is $641.24 million

Selling, general & administrative expenses

$380.25M
OMCL annual SGA is $380.25 million

Depreciation and amortization

$89.75M
OMCL annual depreciation & amortization is $89.75 million

Interest expense

-
OMCL annual interest expense value is unknown

Income tax

$13.06M
OMCL annual income tax is $13.06 million

EBIT & EBITDA

EBIT

$337.00K
OMCL annual earnings before interest & taxes is $337.00 thousand

EBITDA

$90.09M
OMCL annual EBITDA is $90.09 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.12B
OMCL annual total assets is $2.12 billion

Non current assets

$1.31B
OMCL annual long term assets is $1.31 billion

Current assets

$815.49M
OMCL annual total current assets is $815.49 million

Cash and cash equivalents

$369.20M
OMCL annual cash & cash equivalents is $369.20 million

Accounts receivable

$256.40M
OMCL annual accounts receivable is $256.40 million

Inventory

$88.66M
OMCL annual inventory is $88.66 million

Liabilities

Total liabilities

$877.65M
OMCL annual total liabilities is $877.65 million

Long term liabilities

$281.97M
OMCL annual total long term liabilities is $281.97 million

Current liabilities

$595.68M
OMCL annual total current liabilities is $595.68 million

Accounts payable

$51.78M
OMCL annual accounts payable is $51.78 million

Debt

Total debt

$382.55M
OMCL annual total debt is $382.55 million

Total debt 1-year change

-37.71%
OMCL annual total debt is down -37.71% year-on-year

Long term debt

$197.52M
OMCL annual long term debt is $197.52 million

Short term debt

$185.03M
OMCL annual short term debt is $185.03 million

Equity & Capital

Shareholders equity

$1.24B
OMCL annual stockholders equity is $1.24 billion

Book value

$1.24B
OMCL annual book value is $1.24 billion

Retained earnings

$382.89M
OMCL annual retained earnings is $382.89 million

Working capital

$219.81M
OMCL annual working capital is $219.81 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$187.72M
OMCL annual cash flow from operations is $187.72 million

Cash from operations 1-year change

+3.66%
OMCL annual cash flow from operations is up +3.66% year-on-year

Cash from investing

-$52.79M
OMCL annual cash flow from investing activities is -$52.79 million

Cash from investing 1-year change

+4.04%
OMCL annual cash flow from investing activities is up +4.04% year-on-year

Cash from financing

-$235.58M
OMCL annual cash flow from financing activities is -$235.58 million

Cash from financing 1-year change

-1105.88%
OMCL annual cash flow from financing activities is down -1105.88% year-on-year

CAPEX

CAPEX

$52.79M
OMCL annual capital expenditures is $52.79 million

CAPEX 1-year change

-4.04%
OMCL annual capital expenditures is down -4.04% year-on-year

Free Cash Flow

Free cash flow

$134.93M
OMCL annual free cash flow is $134.93 million

Free cash flow 1-year change

+7.02%
OMCL annual free cash flow is up +7.02% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

42.35%
OMCL annual gross profit margin is 42.35%

Operating margin

0.03%
OMCL annual operating profit margin is 0.03%

Net margin

1.13%
OMCL annual net profit margin is 1.13%

ROA & ROE

ROA

0.58%
OMCL annual return on assets is 0.58%

ROE

1.03%
OMCL annual return on equity is 1.03%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

112.15
OMCL price to earnings ratio is 112.15

PE ratio Sector rank

92.65%
OMCL price to earnings ratio is higher than 92.65% of companies in Healthcare sector

PB Ratio

PB ratio

1.14
OMCL price to book ratio is 1.14

PB ratio Sector rank

47.07%
OMCL price to book ratio is higher than 47.07% of companies in Healthcare sector

PS Ratio

PS ratio

1.27
OMCL price to sales ratio is 1.27

PS ratio Sector rank

31.84%
OMCL price to sales ratio is higher than 31.84% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.43B
OMCL enterprise value is $1.43 billion

Enterprise value Sector rank

78.51%
OMCL enterprise value is higher than 78.51% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

15.86
OMCL EV/EBITDA is 15.86

EV/EBITDA Sector rank

88.77%
OMCL EV/EBITDA is higher than 88.77% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.37
OMCL annual current ratio is 1.37

Quick ratio

1.22
OMCL annual quick ratio is 1.22

Leverage

Debt to equity

0.27
OMCL annual debt to equity ratio is 0.27

Interest coverage ratio

-
OMCL annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

6
OMCL piotroski f-score is 6

Altman Z-Score

1.87
OMCL altman z-score is 1.87

Analyst ratings

Recent major analysts updates

Apr 17, 25 Wells Fargo
Equal-Weight
Mar 20, 25 JP Morgan
Neutral
Feb 4, 25 Benchmark
Buy
Jan 13, 25 Wells Fargo
Equal-Weight
Jan 6, 25 B of A Securities
Neutral
Nov 21, 24 JP Morgan
Neutral
Oct 31, 24 Craig-Hallum
Buy
Oct 31, 24 Barclays
Equal-Weight
Oct 31, 24 B of A Securities
Neutral
Oct 14, 24 Wells Fargo
Equal-Weight

Institutional Ownership

Similar stocks

ARWR logo
Arrowhead Pharmaceuticals (ARWR)
IMCR logo
Immunocore Holdings (IMCR)
BEAM logo
Beam Therapeutics (BEAM)
PHR logo
Phreesia (PHR)
NHC logo
National HealthCare (NHC)
ASTH logo
Astrana Health (ASTH)
PACS logo
PACS (PACS)
MNKD logo
MannKind (MNKD)
Disc Medicine (IRON)
  • What is the ticker symbol for Omnicell?
  • Does Omnicell pay dividends?
  • What sector is Omnicell in?
  • What industry is Omnicell in?
  • What country is Omnicell based in?
  • When did Omnicell go public?
  • Is Omnicell in the S&P 500?
  • Is Omnicell in the NASDAQ 100?
  • Is Omnicell in the Dow Jones?
  • When was Omnicell's last earnings report?
  • When does Omnicell report earnings?
  • Should I buy Omnicell stock now?

What is the ticker symbol for Omnicell?

The ticker symbol for Omnicell is NASDAQ:OMCL

Does Omnicell pay dividends?

No, Omnicell does not pay dividends

What sector is Omnicell in?

Omnicell is in the Healthcare sector

What industry is Omnicell in?

Omnicell is in the Health Information Services industry

What country is Omnicell based in?

Omnicell is headquartered in United States

When did Omnicell go public?

Omnicell's initial public offering (IPO) was on August 9, 2001

Is Omnicell in the S&P 500?

No, Omnicell is not included in the S&P 500 index

Is Omnicell in the NASDAQ 100?

No, Omnicell is not included in the NASDAQ 100 index

Is Omnicell in the Dow Jones?

No, Omnicell is not included in the Dow Jones index

When was Omnicell's last earnings report?

Omnicell's most recent earnings report was on Feb 6, 2025

When does Omnicell report earnings?

The next expected earnings date for Omnicell is May 2, 2025

Should I buy Omnicell stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page